IP Library › Granted Patent US 9,963,707
Granted Patent B2
US 9,963,707 · App. 14/433,113 · Granted May 8, 2018

Multiprotein expression cassettes

Inventors: Binzhang Shen (Boston, MA); Jason Donald (Lexington, MA); R. Michael Raab (Arlington, MA)
Assignee: AGRIVIDA, INC.
C12N15/635C07K14/81C12N9/20C12N9/248C12N9/2437C12N9/50C12N9/54C12N9/64C12N15/62C12N15/63C12Y304/21062
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,963,707
App. No.
14/433,113
Granted
May 8, 2018
Kind
B2
Abstract

Methods for expressing multiple proteins by constructing transformation vectors that include multiprotein expression cassettes and transforming hosts with vectors and by engineering hosts expressing multiprotein units are provided. Multiprotein units that include multiple proteins fused to modified inteins capable of effecting splicing of the multiprotein units are described. Expression cassettes that include nucleic acids encoding multiprotein units and hosts including the expression cassettes are also provided.

Claims (19)

1. A multiprotein unit comprising:

i) a modified intein comprising an N-terminal part of an intein, a C-terminal part of the intein and a first protein, wherein a carboxy terminus of the N-terminal part of the intein is fused to an amino terminus of the first protein, and a carboxy terminus of the first protein is fused to an amino terminus of the C-terminal part of the intein, and

ii) a second protein comprising an N-extein and a C-extein, wherein a carboxy terminus of the N-extein is fused to an amino terminus of the N-terminal part of the modified intein, and a carboxy terminus of the C-terminal part of the modified intein is fused to an amino terminus of the C-extein, wherein an amino acid sequence of the N-terminal part of the modified intein starts with a cysteine and an amino acid sequence of the C-terminal part of the modified intein ends with an asparagine, the activity of the first protein and the second protein of the multiprotein unit is reduced or inhibited, and the modified intein effects splicing of the multiprotein unit and restores the activity of the first protein and the second protein, wherein the sequence of the modified intein has at least 90% sequence identity to the reference sequence selected from the group consisting of: SEQ ID NO: 14 [mTth:EU59], SEQ ID NO: 15 [Pho_RadA:EU59], SEQ ID NO: 16 [Tko_RadA:EU59], SEQ ID NO:143 [mTth:O59_1], SEQ ID NO: 144 [mTth:O59_2], SEQ ID NO:145 [mTth:O59_3], SEQ ID NO:146 [mTth:O59_4], SEQ ID NO:147 [mTth:O59_5], SEQ ID NO:148 [mTth:O59_6], and SEQ ID NO: 232 [mTth:P77Cd].

2. The multiprotein unit of claim 1 , wherein the sequence of the modified intein has at least 90% sequence identity to the reference sequence of SEQ ID NO: 14 [mTth:EU59].

3. The multiprotein unit of claim 1 , wherein the sequence of the multiprotein unit has at least 90% sequence identity to the reference sequence selected from the group consisting of: SEQ ID NO: 19 [NtEGS109:mTth:EU59], SEQ ID NO: 20 [NtEGT155:mTth:EU59], SEQ ID NO: 21 [NtEGS255:mTth:EU59], SEQ ID NO: 22 [NtEGS325:mTth:EU59], SEQ ID NO: 23 [NtEGC348:mTth:EU59], SEQ ID NO: 24 [NtEGS352:mTth:EU59], SEQ ID NO: 25 [NtEGS364:mTth:EU59], SEQ ID NO: 26 [NtEGT376:mTth:EU59], SEQ ID NO: 27 [NtEGS379:mTth:EU59], SEQ ID NO: 28 [P33S231:mTth:EU59] SEQ ID NO: 29 [P33S235:mTth:EU59], SEQ ID NO: 30 [P33S303:mTth:EU59], SEQ ID NO: 31 [P33S318:mTth:EU59], SEQ ID NO: 32 [AAQS121:mTth:EU59], SEQ ID NO: 33 [AAQS138:mTth:EU59], SEQ ID NO: 34 [AAQS140:mTth:EU59], SEQ ID NO: 35 [AAQS146:mTth:EU59], SEQ ID NO: 36 [AAQS179:mTth:EU59], SEQ ID NO: 37 [AAQS187:mTth:EU59], SEQ ID NO: 38 [AAQS222:mTth:EU59], SEQ ID NO: 39 [AAQS249:mTth:EU59], SEQ ID NO: 40 [AAQS251:mTth:EU59], SEQ ID NO: 41 [NtEGS352:mTth-c:EU59], SEQ ID NO: 42 [NtEGS364:mTth-c:EU59], SEQ ID NO: 43 [NtEGS149:Pho_RadA:EU59], SEQ ID NO: 44 [NtEGT179: Pho_RadA: EU59], SEQ ID NO: 45 [NtEGT200: Pho_RadA: EU59], SEQ ID NO: 46 [NtEGS352: Pho_RadA: EU59], SEQ ID NO: 47 [NtEGS149: Tko_RadA: EU59], SEQ ID NO: 48 [NtEGT179: Tko_RadA: EU59], SEQ ID NO: 49 [NtEGT200: Tko_RadA: EU59], SEQ ID NO: 50 [NtEGS352: Tko_RadA: EU59], SEQ ID NO: 171[iproSav S46:mTth:EU59], SEQ ID NO: 172 [iproSav S62:mTth:EU59], SEQ ID NO: 173 [iproSav T47:mTth:EU59], SEQ ID NO: 174 [iproSav S86:mTth:EU59], SEQ ID NO: 175 [iproSav S100:mTth:EU59], SEQ ID NO: 176 [iproSav T109:mTth:EU59], SEQ ID NO: 177 [iproSav S135:mTth:EU59], SEQ ID NO: 178 [iproSav T148:mTth:EU59], SEQ ID NO: 179 [iproSav S166:mTth:EU59], SEQ ID NO: 180 [iproSav T167:mTth:EU59], SEQ ID NO: 181 [iproSav S196:mTth:EU59], SEQ ID NO: 182 [iproSav 5208:mTth:EU59], SEQ ID NO: 183 [iproSav 5239:mTth:EU59], SEQ ID NO: 184 [iproSav T243:mTth:EU59], SEQ ID NO: 185 [iproSav 5269:mTth:EU59], SEQ ID NO: 186 [iproSav T285:mTth:EU59], SEQ ID NO: 187 [iproSav 5293:mTth:EU59], SEQ ID NO: 188 [iproSav 5317:mTth:EU59], SEQ ID NO: 189 [iproSav T318:mTth:EU59], SEQ ID NO: 190 [iproSav T329:mTth:EU59], SEQ ID NO: 209 [iproSavS135:mTth:O59_1], SEQ ID NO: 210 [iproSavS135:mTth:O59_2], SEQ ID NO: 211 [iproSavS135:mTth:O59_3], SEQ ID NO: 212 [iproSavS135:mTth:O59_4], SEQ ID NO: 213 [iproSavS135:mTth:O59_5], SEQ ID NO: 214 [iproSavS135:mTth:O59_6], SEQ ID NO: 233 [iproSavS135: mTth:P77Cd], SEQ ID NO: 234 [iproSavS269: mTth:P77Cd], SEQ ID NO: 235 [iproSavS293: mTth:P77Cd], and SEQ ID NO: 236 [iproSavS317: mTth:P77Cd].

4. The multiprotein unit of claim 3 , wherein the sequence of the multiprotein unit has at least 90% sequence identity to the reference sequence selected from the group consisting of: SEQ ID NO: 23 [NtEGC348:mTth:EU59], SEQ ID NO: 24 [NtEGS352:mTth:EU59], and SEQ ID NO: 26 [NtEGT376:mTth:EU59].

5. The multiprotein unit of claim 1 , wherein the protein selected as the first protein differs from the protein selected as the second protein.

6. The multiprotein unit of claim 1 , wherein the sequence of the intein has at least 90% sequence identity to the reference sequence selected from the group consisting of: SEQ ID NO: 9 (mTth), SEQ ID NO: 10 (Pho_RadA), and SEQ ID NO: 11 (Tko_RadA).

7. The multiprotein unit of claim 1 , wherein the modified intein is inducible to cause splicing of the multiprotein unit by exposure of the multiprotein unit to an induction condition.

8. The multiprotein unit of claim 7 , wherein the induction condition is at least one condition selected from the group consisting of: an induction temperature, an induction pH, an induction light, an induction compound, an induction concentration of a compound, and an induction concentration of an ion.

9. The multiprotein unit of claim 1 , wherein the modified intein splices spontaneously.

10. The multiprotein unit of claim 1 , wherein the second protein is selected from the group consisting of: a protease, a phytase, an amylase, an invertase, a xylanase, an endoglucanase, an exoglucanase, a feruloyl esterase, a lipase, and a cellulase.

11. The multiprotein unit of claim 1 , wherein the sequence of the second protein has at least 90% sequence identity to the reference sequence selected from the group consisting of: SEQ ID NO: 1[P29600], SEQ ID NO: 2[P33558], SEQ ID NO: 3[Q7WUM6; AAQ], SEQ ID NO: 4[P77853], SEQ ID NO: 5 [P77853Cd], SEQ ID NO: 6[EU591743], SEQ ID NO: 7 [077044; NtEG], SEQ ID NO: 8[059952], SEQ ID NO: 17 [Savinase catalytic domain], and SEQ ID NO: 149 [proSavinase].

12. The multiprotein unit of claim 1 , wherein the multiprotein unit is encoded by at least one polynucleotide included in an expression cassette and expressed in a host organism.

13. The multiprotein unit of claim 12 , wherein the multiprotein unit is expressed in the host selected from the group consisting of: a plant, a yeast, a bacterium, a mammalian cell, an insect cell, and a phage.

14. A multiprotein unit comprising:

i) a modified intein comprising an N-terminal part of an intein, a C-terminal part of the intein and a first protein, wherein a carboxy terminus of the N-terminal part of the intein is fused to an amino terminus of the first protein, and a carboxy terminus of the first protein is fused to an amino terminus of the C-terminal part of the intein, and

ii) a second protein comprising an N-extein and a C-extein, wherein a carboxy terminus of the N-extein is fused to an amino terminus of the N-terminal part of the modified intein, and a carboxy terminus of the C-terminal part of the modified intein is fused to an amino terminus of the C-extein, wherein an amino acid sequence of the N-terminal part of the modified intein starts with a cysteine and an amino acid sequence of the C-terminal part of the modified intein ends with an asparagine, the activity of the first protein and the second protein of the multiprotein unit is reduced or inhibited, and the modified intein effects splicing of the multiprotein unit and restores the activity of the first protein and the second protein, wherein the sequence of the multiprotein unit has at least 90% sequence identity to the reference sequence selected from the group consisting of: SEQ ID NO: 19 [NtEGS109:mTth:EU59], SEQ ID NO: 20 [NtEGT155:mTth:EU59], SEQ ID NO: 21 [NtEGS255:mTth:EU59], SEQ ID NO: 22 [NtEGS325:mTth:EU59], SEQ ID NO: 23 [NtEGC348:mTth:EU59], SEQ ID NO: 24 [NtEGS352:mTth:EU59], SEQ ID NO: 25 [NtEGS364:mTth:EU59], SEQ ID NO: 26 [NtEGT376:mTth:EU59], SEQ ID NO: 27 [NtEGS379:mTth:EU59], SEQ ID NO: 28 [P33S231:mTth:EU59] SEQ ID NO: 29 [P33S235:mTth:EU59], SEQ ID NO: 30 [P33S303:mTth:EU59], SEQ ID NO: 31 [P33S318:mTth:EU59], SEQ ID NO: 32 [AAQS121:mTth:EU59], SEQ ID NO: 33 [AAQS138:mTth:EU59], SEQ ID NO: 34 [AAQS140:mTth:EU59], SEQ ID NO: 35 [AAQS146:mTth:EU59], SEQ ID NO: 36 [AAQS179:mTth:EU59], SEQ ID NO: 37 [AAQS187:mTth:EU59], SEQ ID NO: 38 [AAQS222:mTth:EU59], SEQ ID NO: 39 [AAQS249:mTth:EU59], SEQ ID NO: 40 [AAQS251:mTth:EU59], SEQ ID NO: 41 [NtEGS352:mTth-c:EU59], SEQ ID NO: 42 [NtEGS364:mTth-c:EU59], SEQ ID NO: 43 [NtEGS149:Pho_RadA:EU59], SEQ ID NO: 44 [NtEGT179: Pho_RadA: EU59], SEQ ID NO: 45 [NtEGT200: Pho_RadA: EU59], SEQ ID NO: 46 [NtEGS352: Pho_RadA: EU59], SEQ ID NO: 47 [NtEGS149: Tko_RadA: EU59], SEQ ID NO: 48 [NtEGT179: Tko_RadA: EU59], SEQ ID NO: 49 [NtEGT200: Tko_RadA: EU59], SEQ ID NO: 50 [NtEGS352: Tko_RadA: EU59], SEQ ID NO: 171[iproSav S46:mTth:EU59], SEQ ID NO: 172 [iproSav S62:mTth:EU59], SEQ ID NO: 173 [iproSav T47:mTth:EU59], SEQ ID NO: 174 [iproSav S86:mTth:EU59], SEQ ID NO: 175 [iproSav S100:mTth:EU59], SEQ ID NO: 176 [iproSav T109:mTth:EU59], SEQ ID NO: 177 [iproSav 5135:mTth:EU59], SEQ ID NO: 178 [iproSav T148:mTth:EU59], SEQ ID NO: 179 [iproSav 5166:mTth:EU59], SEQ ID NO: 180 [iproSav T167:mTth:EU59], SEQ ID NO: 181 [iproSav 5196:mTth:EU59], SEQ ID NO: 182 [iproSav 5208:mTth:EU59], SEQ ID NO: 183 [iproSav 5239:mTth:EU59], SEQ ID NO: 184 [iproSav T243:mTth:EU59], SEQ ID NO: 185 [iproSav 5269:mTth:EU59], SEQ ID NO: 186 [iproSav T285:mTth:EU59], SEQ ID NO: 187 [iproSav 5293:mTth:EU59], SEQ ID NO: 188 [iproSav 5317:mTth:EU59], SEQ ID NO: 189 [iproSav T318:mTth:EU59], SEQ ID NO: 190 [iproSav T329:mTth:EU59], SEQ ID NO: 209 [iproSavS135:mTth:O59_1], SEQ ID NO: 210 [iproSavS135:mTth:O59_2], SEQ ID NO: 211 [iproSavS135:mTth:O59_3], SEQ ID NO: 212 [iproSavS135:mTth:O59_4], SEQ ID NO: 213 [iproSavS135:mTth:O59_5], SEQ ID NO: 214 [iproSavS135:mTth:O59_6], SEQ ID NO: 233 [iproSavS135: mTth:P77Cd], SEQ ID NO: 234 [iproSavS269: mTth:P77Cd], SEQ ID NO: 235 [iproSavS293: mTth:P77Cd], and SEQ ID NO: 236 [iproSavS317: mTth:P77Cd].

15. The multiprotein unit of claim 14 , wherein the sequence of the multiprotein unit has at least 90% sequence identity to the reference sequence selected from the group consisting of: SEQ ID NO: 23 [NtEGC348:mTth:EU59], SEQ ID NO: 24 [NtEGS352:mTth:EU59], and SEQ ID NO: 26 [NtEGT376:mTth:EU59].

Assignments (3)
MERGER Recorded Nov 9, 2023
From: AGRIVIDA MERGER SUB, INC.; AGRIVIDA, INC.
To: AGRIVIDA INC.
Reel/Frame 065513/0941 →
CHANGE OF ADDRESS Recorded Mar 9, 2018
From: AGRIVIDA, INC.
To: AGRIVIDA, INC.
Reel/Frame 045542/0924 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2015
From: SHEN, BINZHANG; DONALD, JASON; RAAB, R. MICHAEL
To: AGRIVIDA, INC.
Reel/Frame 035319/0572 →
Continuity (3)
Provisional Application 61783424 · Mar 14, 2013
Provisional Application 61744863 · Oct 3, 2012
Related Publication 20150267206A1 · Sep 24, 2015